| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T647 |
4-14 |
GO:0010467 |
denotes |
expression |
| T648 |
18-21 |
PR:000029150 |
denotes |
HLA |
| T649 |
28-32 |
PR:000001889 |
denotes |
CD14 |
| T650 |
33-42 |
CL:0000576 |
denotes |
monocytes |
| T78000 |
39-45 |
UBERON:0001969 |
denotes |
tes wa |
| T62942 |
47-57 |
GO:0065007 |
denotes |
strongly i |
| T651 |
69-77 |
SP_7 |
denotes |
COVID-19 |
| T652 |
78-84 |
UBERON:0001969 |
denotes |
plasma |
| T73958 |
90-94 |
PR:000001393 |
denotes |
pati |
| T4451 |
103-115 |
DG_35 |
denotes |
immune dysr |
| T653 |
104-110 |
UBERON:0002405 |
denotes |
immune |
| T654 |
111-124 |
GO:0065007 |
denotes |
dysregulation |
| T655 |
136-142 |
UBERON:0001969 |
denotes |
plasma |
| T60524 |
156-159 |
PR:000029150 |
denotes |
wi |
| T50596 |
166-170 |
PR:000001889 |
denotes |
nter |
| T33458 |
171-180 |
CL:0000576 |
denotes |
ediate im |
| T656 |
178-184 |
UBERON:0002405 |
denotes |
immune |
| T7540 |
212-222 |
SP_7 |
denotes |
s 5C–5F); |
| T18315 |
228-233 |
UBERON:0002405 |
denotes |
ditio |
| T79191 |
234-247 |
GO:0065007 |
denotes |
of the speci |
| T657 |
266-270 |
PR:000001393 |
denotes |
IL-6 |
| T658 |
279-290 |
DG_35 |
denotes |
Tocilizumab |
| T30207 |
287-293 |
UBERON:0001969 |
denotes |
mab pa |
| T4094 |
295-305 |
GO:0065007 |
denotes |
ially rest |
| T659 |
314-324 |
GO:0010467 |
denotes |
expression |
| T660 |
328-331 |
PR:000029150 |
denotes |
HLA |
| T92474 |
338-342 |
PR:000001393 |
denotes |
mono |
| T661 |
338-347 |
CL:0000576 |
denotes |
monocytes |
| T42158 |
351-362 |
DG_35 |
denotes |
all patient |
| T662 |
369-375 |
UBERON:0002405 |
denotes |
immune |
| T663 |
376-389 |
GO:0065007 |
denotes |
dysregulation |
